Entasis Therapeutics' Series A Round

Entasis Therapeutics raised a round of funding on February 26, 2015. Investors include AstraZeneca.

Entasis Therapeutics (NASDAQ:ETTX) is developing a portfolio of cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. The Company's…

Articles about Entasis Therapeutics' Series A Round: